The best synthetic data tools for software testing in regulated industries include platforms like K2view, MOSTLY AI, Tonic.ai, Delphix, Syntho, and bluegen.live, each offering privacy-safe data generation built around compliance frameworks such as GDPR, HIPAA, and PCI DSS. The right choice depends on your industry, data complexity, and how deeply the tool needs to integrate with your testing pipeline. This article answers the most important questions about synthetic data for regulated software testing, from what it actually is to how you evaluate its quality before using it in production.

What makes synthetic data different from anonymized or masked test data?

Synthetic data is entirely artificial and is never derived from real production records. Anonymized or masked data, by contrast, starts from actual customer or patient records and transforms them by hiding or replacing sensitive fields. The fundamental difference is origin: synthetic data changes the starting point entirely, while anonymization only changes what you see from the same starting point.

Test data masking works by replacing identifiable values with non-identifiable substitutes while preserving the structure and usability of the original dataset. It is a well-established technique, and when done carefully, it reduces re-identification risk significantly. However, because masked data is still derived from production records, it carries an inherent dependency on those records. Researchers and regulators have demonstrated that even well-masked datasets can sometimes be re-identified through inference, particularly when combined with external data sources.

Synthetic data generation sidesteps this problem by creating statistically representative datasets that were never linked to any real individual. Because the data is artificially generated from scratch, it inherently avoids the compliance risks associated with handling sensitive information. This also unlocks a practical advantage for testing teams: synthetic datasets can be tailored to cover edge cases, unusual data patterns, and new business scenarios that may simply not exist in production data at all.

The trade-off worth acknowledging is that synthetic data, precisely because it is artificial, may not capture every real-world complexity. Rare dependencies, legacy data quirks, and subtle multi-entity relationships that exist in production can be difficult to replicate faithfully. This is why understanding the distinction between the two approaches matters: they are complementary tools rather than direct replacements for each other.

Which regulated industries benefit most from synthetic test data?

Healthcare and financial services benefit most from synthetic test data, followed closely by insurance, energy, government, and telecommunications. These sectors share a common challenge: they hold large volumes of highly sensitive data and operate under strict regulatory frameworks that make using production data in testing environments legally risky and operationally complex.

In healthcare, organizations must comply with frameworks like HIPAA in the United States and GDPR in Europe, both of which impose significant restrictions on how patient data can be accessed and shared. Synthetic data offers a legally defensible alternative, generating statistically equivalent but entirely fictitious patient profiles that eliminate re-identification risk. Regulatory bodies including the FDA and the European Medicines Agency have both issued guidance acknowledging synthetic data as a valid tool in clinical and regulatory contexts, which has accelerated adoption across health systems and research institutions.

Financial services face equally demanding oversight. Institutions must navigate SOX compliance requirements, PCI DSS standards, and a growing body of national and regional data protection laws. Synthetic data allows development and QA teams to simulate fraud patterns, test edge cases in transaction processing, and build models without exposing real customer records. According to industry reporting on financial services, organizations using synthetic data to navigate regulatory constraints have reported meaningful reductions in model development time, since teams no longer wait for lengthy data provisioning and approval cycles before beginning work.

Government and public sector organizations face their own layer of complexity. Many agencies require specific approval processes for synthetic data generation and impose strict limitations on how synthetic datasets can be shared across departments or used for research. Energy and telecommunications companies are increasingly affected by emerging regulations around critical infrastructure protection, including the EU’s NIS2 directive, which has expanded the scope of sectors subject to data governance requirements.

Across all of these verticals, a striking gap remains: test environment compliance research suggests that only a small fraction of companies fully comply with global data privacy regulations in their test environments. Synthetic data tools exist precisely to close that gap.

What features should a synthetic data tool have for regulated environments?

A synthetic data tool built for regulated environments must deliver five core capabilities: statistical fidelity, compliance and governance controls, referential integrity across complex data structures, CI/CD integration, and customizability for domain-specific rules. Without all five, the tool will either fail audits, produce invalid test scenarios, or create bottlenecks in development workflows.

Compliance and governance controls

For regulated industries, a tool must support the specific frameworks that govern your sector. GDPR, HIPAA, CPRA, PCI DSS, and SOX are the most commonly required, but sector-specific requirements add further layers. Built-in audit trails, role-based access controls, and compliance reporting are not optional extras in these environments. They are the evidence that demonstrates to regulators and internal auditors that data handling practices meet the required standard. California’s AB 2013 Gen AI Training Data Transparency Act, which took effect in January 2026, introduced new disclosure requirements around the use of synthetic data in generative AI systems, adding another compliance consideration for tool vendors and the organizations that use them.

Referential integrity and data fidelity

In enterprise environments, data rarely lives in a single table. Healthcare records involve complex relationships between patients, encounters, medications, diagnoses, and providers. Financial data involves transactional hierarchies, account relationships, and time-series dependencies. A synthetic data tool that fails to preserve foreign key relationships and business rules across these structures will produce datasets that look plausible in isolation but generate misleading results in functional and integration testing. Referential integrity is the feature that separates enterprise-grade tools from simpler generators.

Developer self-service and pipeline integration

Regulated environments often have centralized data teams that become bottlenecks when every test data request requires manual review and provisioning. Tools that offer self-service interfaces empower developers and testers to generate compliant datasets independently, without waiting for a central team to action each request. API access and automated triggers extend this further, allowing synthetic data generation to be embedded directly into CI/CD workflows so that every new build or test run can request fresh, privacy-compliant data on demand.

What are the best synthetic data tools for software testing in regulated industries?

The leading synthetic data tools for regulated software testing in 2026 include K2view, MOSTLY AI, Tonic.ai, Delphix, Syntho, Gretel (now part of NVIDIA), Hazy (rebranded as Data Maker following acquisition by SAS), Synthea, MDClone, and bluegen.live. Each has distinct strengths depending on the industry, data type, and integration requirements.

K2view uses a patented entity-based approach to ensure referential integrity across complex relational datasets. It supports GDPR, CPRA, and HIPAA compliance and integrates with CI/CD pipelines, making it a strong choice for enterprises managing large, interconnected data structures in financial services or healthcare.

MOSTLY AI generates privacy-safe synthetic datasets that preserve the statistical properties of source data. It includes built-in quality reports covering fidelity, utility, and privacy metrics, and offers fairness tooling for sensitive attributes. A free tier makes it accessible for smaller teams exploring synthetic data for the first time.

Tonic.ai offers three distinct products: Tonic Fabricate for generating synthetic data from scratch using AI, Tonic Structural for test data management, and Tonic Textual for redacting and synthesizing unstructured data. This suite approach is particularly useful for organizations dealing with both structured databases and free-text documents in the same testing pipeline.

Delphix integrates synthetic data generation into a broader data management and masking platform. It is widely adopted in regulated industries where governance, privacy, and speed of delivery are all critical, and introduced AI-powered synthetic data generation capabilities in 2025.

Gretel, now part of NVIDIA’s NeMo ecosystem following a 2025 acquisition, specializes in privacy-preserving synthetic data for tabular, time-series, and natural language data. Its SDK and pipeline tooling make generation repeatable and version-controllable, which suits engineering teams that treat synthetic data as part of CI/CD rather than a manual export process.

Synthea is an open-source synthetic patient generator developed by MITRE, widely used in healthcare testing. It produces complete medical histories and exports data in HL7 FHIR, C-CDA, and CSV formats, at no cost and with no privacy restrictions. It is a practical starting point for health system testing teams with limited budgets.

MDClone provides the ADAMS Platform, a self-service healthcare data exploration environment. Its Synthetic Data Engine converts real EHR records into statistically comparable synthetic versions while maintaining correlations among clinical variables, making it a specialized tool for health systems and medical research institutions.

bluegen.live is a Dutch company built from the ground up for the European market, with GDPR compliance by design. We support complex relational data structures, including many-to-many relationships, and serve regulated industries including healthcare, finance, and energy. Our platform is used by European enterprise clients and government organizations that need synthetic data generation aligned with both EU privacy law and the operational realities of large-scale testing environments.

Pricing across most enterprise tools is not publicly listed and requires direct vendor engagement. The factors that typically influence cost include data volume, the number of connected data sources, the complexity of relational structures, compliance reporting requirements, and the level of support and customization needed. Open-source options like Synthea and the Synthetic Data Vault (SDV) are free to use but require technical implementation effort.

How do synthetic data tools integrate with CI/CD testing pipelines?

Synthetic data tools integrate with CI/CD pipelines primarily through RESTful APIs and command-line interfaces that allow orchestration tools like Jenkins, GitLab CI/CD, and Azure DevOps to request fresh, privacy-compliant datasets automatically on every new build or test run. This eliminates the manual data provisioning step that typically delays testing cycles in regulated environments.

The practical benefit of this integration is consistency. When synthetic data generation is triggered programmatically as part of a pipeline, every environment, from development through staging to pre-production, receives datasets generated from the same rules and parameters. This removes the variability that comes from teams using different data snapshots or manually prepared test files, which is a common source of hard-to-diagnose test failures.

Synthetic data also supports shift-left testing, the practice of moving testing earlier in the development lifecycle. When developers can generate compliant test data independently without waiting for a central data team to provision and approve it, they can write and run tests from the earliest stages of feature development. This reduces the cost of finding defects and shortens overall release cycles. Between roughly 60% and 75% of global enterprises now use synthetic data for software testing and integration testing, according to Perforce’s 2025 State of Synthetic Data Report, reflecting how mainstream this practice has become in DevOps-oriented organizations.

Tools like Gretel (now within NVIDIA’s ecosystem) treat synthetic data as a versioned, reproducible artifact rather than a manual export. This means datasets can be tracked alongside code in version control, regenerated on a schedule, and updated automatically when business rules or data schemas change. For regulated industries where audit trails matter, this version-controlled approach also provides documentation of exactly what data was used in each test run.

Can synthetic data fully replace production data in software testing?

Synthetic data cannot fully replace production data in software testing, but it can cover the large majority of testing needs. Industry experience suggests synthetic data handles around 80 to 90 percent of testing scenarios effectively. The remaining cases, particularly regression testing against real-world patterns, reproducing specific production bugs, and final user acceptance testing, still benefit from properly masked production data.

The scenarios where synthetic data excels are well-defined. Unit tests, integration tests, CI/CD pipeline runs, performance and load testing at scale, and any situation involving privacy-regulated data are all strong candidates for a synthetic-first approach. Synthetic data is also the right choice when you need to test edge cases or data volumes that simply do not exist in production yet, such as simulating a new market, a product launch, or an unusual transaction pattern.

Where synthetic data reaches its limits is in scenarios that depend on the specific, idiosyncratic characteristics of real production data. Complex multi-entity relationships built up over years, legacy data quirks introduced by historical system migrations, and rare combinations of values that occur in practice but were never anticipated during synthetic data design are all areas where production data (masked appropriately) provides more reliable test coverage. Synthetic data may also inadvertently amplify biases present in the training data used to build the generation model, which is a meaningful concern in regulated industries where model fairness is subject to audit.

Gartner has projected that by 2026, the majority of data used in AI and analytics projects will be synthetically generated. The same trend is reaching QA and software engineering, driven by the dual pressures of data minimization requirements under privacy law and speed-to-test demands under agile and DevOps delivery models. The practical conclusion most organizations reach is a hybrid model: synthetic data for the bulk of testing, with masked production data reserved for final validation.

How do you evaluate synthetic data quality before using it in testing?

Synthetic data quality is evaluated across three dimensions: fidelity, utility, and privacy. Fidelity measures how closely the synthetic data matches the statistical properties of the original. Utility measures how well it supports the downstream task, such as training a model or running a test suite. Privacy measures whether the data protects against re-identification attacks. No dataset can be optimized for all three simultaneously, so evaluation must be tied to the specific use case.

Measuring fidelity and utility

Fidelity is assessed using statistical similarity measures that compare distributions between the synthetic and original datasets. Common metrics include the KS Test, KL Divergence, and Wasserstein Distance, each of which captures different aspects of how well the synthetic distribution mirrors the real one. For structured relational data, fidelity also includes preserving sequences, time-series patterns, and cross-table relationships.

Utility is most commonly evaluated using the “Train on Synthetic, Test on Real” method, which compares the performance of a model trained on synthetic data against one trained on real data. If the two models perform similarly on a held-out real dataset, the synthetic data has strong utility for that task. Feature importance stability and query similarity scores are additional utility indicators worth tracking.

Measuring privacy

Privacy evaluation focuses on resistance to re-identification. The key metrics are Membership Inference Risk, which estimates the probability that an attacker could identify whether a specific individual’s record was used in generating the synthetic data, and Distance to Closest Record, which measures how similar synthetic records are to their nearest real counterparts. A dataset with high utility but weak privacy scores may still expose individuals to inference attacks, which is a compliance risk in any regulated environment.

One important practical note: synthetic data quality is not a one-time check. Datasets drift over time as real-world patterns evolve, business rules change, and new data types are introduced. Teams should treat synthetic data validation as a continuous process embedded in their data pipeline, not a gate that is passed once at initial generation. Tools like MOSTLY AI include built-in quality reporting that surfaces fidelity, utility, and privacy metrics automatically, which reduces the manual overhead of ongoing validation.

How BlueGen helps with synthetic data for regulated software testing

Choosing the right synthetic data platform is one thing — having it work reliably within the compliance and operational constraints of a regulated environment is another. bluegen.live is purpose-built for exactly this challenge, combining GDPR-by-design architecture with the depth of relational data support that enterprise testing environments require.

Here is what BlueGen brings to regulated testing workflows:

• GDPR compliance by design: BlueGen was built from the ground up for the European regulatory landscape, making it a natural fit for organizations subject to GDPR, as well as sector-specific frameworks in healthcare, finance, and energy.
• Complex relational data support: The platform handles many-to-many relationships and multi-table structures, preserving referential integrity across the datasets your test suites depend on.
• Self-service data generation: Development and QA teams can generate compliant synthetic datasets independently, removing the bottleneck of centralized data provisioning and accelerating testing cycles.
• CI/CD pipeline integration: BlueGen connects with existing DevOps tooling via API, enabling automated, on-demand data generation as part of every build or test run.
• Built-in quality validation: Fidelity, utility, and privacy metrics are surfaced automatically, giving teams the evidence they need for internal audits and regulatory review.
• Proven in regulated industries: BlueGen is used by European enterprise clients and government organizations, including in healthcare, financial services, and energy sectors.

If your organization needs synthetic data generation that is compliant, scalable, and ready for the demands of regulated software testing, request a demo to see bluegen.live in action with your specific use case.